SCM
ETNB

Superstring Capital Management’s 89bio ETNB Stock Holding History

Superstring Capital Management’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-384,652
Closed -$5.65M – 48
2025
Q3 		$5.65M Buy
384,652
+172,275
+81% +$1.76M 5.57% 4
2025
Q2 		$2.09M Buy
212,377
+103,221
+95% +$855K 2.47% 15
2025
Q1 		$794K Sell
109,156
-23,826
-18% -$208K 0.94% 25
2024
Q4 		$1.04M Sell
132,982
-462,221
-78% -$3.81M 0.9% 27
2024
Q3 		$4.4M Sell
595,203
-85,200
-13% -$716K 3.86% 12
2024
Q2 		$5.45M Sell
680,403
-260,884
-28% -$2.33M 6.87% 5
2024
Q1 		$11M Sell
941,287
-80,190
-8% -$888K 7.24% 3
2023
Q4 		$11.4M Buy
+1,021,477
New +$9.39M 8.14% 3

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Superstring Capital Management's ETNB Position: Q4 2025 in Review

Superstring Capital Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 384,652 shares — an estimated $5.65M sold.

Superstring Capital Management first reported a position in ETNB in Q4 2023 and held it in 8 quarters. The position peaked at $11.4M in Q4 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Superstring Capital Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Superstring Capital Management sold 384,652 89bio shares in Q4 2025, an estimated $5.65M.
  • Superstring Capital Management first reported a position in 89bio in Q4 2023 and held it in 8 quarters.
  • Superstring Capital Management's 89bio position peaked at $11.4M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Superstring Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.